0
     

Report Added
Report already added
Premature Ejaculation Treatment Market - Global Outlook and Forecast 2021-2027

Premature Ejaculation Treatment Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Premature Ejaculation Treatment in Global, including the following market information:
Global Premature Ejaculation Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)

The global Premature Ejaculation Treatment market was valued at 2722.6 million in 2020 and is projected to reach US$ 3819.7 million by 2027, at a CAGR of 8.8% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Premature Ejaculation Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Premature Ejaculation Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Premature Ejaculation Treatment Market Segment Percentages, By Type, 2020 (%)
Antidepressants(SSRIs)
Phosphodiesterase-5 Inhibitors
Topical Anesthetics
Analgesics
Other Treatment

China Premature Ejaculation Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Premature Ejaculation Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Retail Pharmacy
Online Pharmacy
Other

Global Premature Ejaculation Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Premature Ejaculation Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Premature Ejaculation Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Premature Ejaculation Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer
Novartis
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Bayer
Menarini
Teva
Sunrise Pharma
Regent Pacific
Torrent Pharma
Vivus
1 Introduction to Research & Analysis Reports
1.1 Premature Ejaculation Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Premature Ejaculation Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Premature Ejaculation Treatment Overall Market Size
2.1 Global Premature Ejaculation Treatment Market Size: 2021 VS 2027
2.2 Global Premature Ejaculation Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Premature Ejaculation Treatment Players in Global Market
3.2 Top Global Premature Ejaculation Treatment Companies Ranked by Revenue
3.3 Global Premature Ejaculation Treatment Revenue by Companies
3.4 Top 3 and Top 5 Premature Ejaculation Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Premature Ejaculation Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Premature Ejaculation Treatment Players in Global Market
3.6.1 List of Global Tier 1 Premature Ejaculation Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Premature Ejaculation Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Premature Ejaculation Treatment Market Size Markets, 2021 & 2027
4.1.2 Antidepressants(SSRIs)
4.1.3 Phosphodiesterase-5 Inhibitors
4.1.4 Topical Anesthetics
4.1.5 Analgesics
4.1.6 Other Treatment
4.2 By Type - Global Premature Ejaculation Treatment Revenue & Forecasts
4.2.1 By Type - Global Premature Ejaculation Treatment Revenue, 2016-2021
4.2.2 By Type - Global Premature Ejaculation Treatment Revenue, 2022-2027
4.2.3 By Type - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Premature Ejaculation Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Other
5.2 By Application - Global Premature Ejaculation Treatment Revenue & Forecasts
5.2.1 By Application - Global Premature Ejaculation Treatment Revenue, 2016-2021
5.2.2 By Application - Global Premature Ejaculation Treatment Revenue, 2022-2027
5.2.3 By Application - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Premature Ejaculation Treatment Market Size, 2021 & 2027
6.2 By Region - Global Premature Ejaculation Treatment Revenue & Forecasts
6.2.1 By Region - Global Premature Ejaculation Treatment Revenue, 2016-2021
6.2.2 By Region - Global Premature Ejaculation Treatment Revenue, 2022-2027
6.2.3 By Region - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Premature Ejaculation Treatment Revenue, 2016-2027
6.3.2 US Premature Ejaculation Treatment Market Size, 2016-2027
6.3.3 Canada Premature Ejaculation Treatment Market Size, 2016-2027
6.3.4 Mexico Premature Ejaculation Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Premature Ejaculation Treatment Revenue, 2016-2027
6.4.2 Germany Premature Ejaculation Treatment Market Size, 2016-2027
6.4.3 France Premature Ejaculation Treatment Market Size, 2016-2027
6.4.4 U.K. Premature Ejaculation Treatment Market Size, 2016-2027
6.4.5 Italy Premature Ejaculation Treatment Market Size, 2016-2027
6.4.6 Russia Premature Ejaculation Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Premature Ejaculation Treatment Market Size, 2016-2027
6.4.8 Benelux Premature Ejaculation Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Premature Ejaculation Treatment Revenue, 2016-2027
6.5.2 China Premature Ejaculation Treatment Market Size, 2016-2027
6.5.3 Japan Premature Ejaculation Treatment Market Size, 2016-2027
6.5.4 South Korea Premature Ejaculation Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Premature Ejaculation Treatment Market Size, 2016-2027
6.5.6 India Premature Ejaculation Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Premature Ejaculation Treatment Revenue, 2016-2027
6.6.2 Brazil Premature Ejaculation Treatment Market Size, 2016-2027
6.6.3 Argentina Premature Ejaculation Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Premature Ejaculation Treatment Revenue, 2016-2027
6.7.2 Turkey Premature Ejaculation Treatment Market Size, 2016-2027
6.7.3 Israel Premature Ejaculation Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Premature Ejaculation Treatment Market Size, 2016-2027
6.7.5 UAE Premature Ejaculation Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Premature Ejaculation Treatment Major Product Offerings
7.1.4 Pfizer Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Premature Ejaculation Treatment Major Product Offerings
7.2.4 Novartis Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Premature Ejaculation Treatment Major Product Offerings
7.3.4 Eli Lilly Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.3.5 Eli Lilly Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Premature Ejaculation Treatment Major Product Offerings
7.4.4 Johnson & Johnson Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Premature Ejaculation Treatment Major Product Offerings
7.5.4 GlaxoSmithKline Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.5.5 GlaxoSmithKline Key News
7.6 Bayer
7.6.1 Bayer Corporate Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Premature Ejaculation Treatment Major Product Offerings
7.6.4 Bayer Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.6.5 Bayer Key News
7.7 Menarini
7.7.1 Menarini Corporate Summary
7.7.2 Menarini Business Overview
7.7.3 Menarini Premature Ejaculation Treatment Major Product Offerings
7.4.4 Menarini Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.7.5 Menarini Key News
7.8 Teva
7.8.1 Teva Corporate Summary
7.8.2 Teva Business Overview
7.8.3 Teva Premature Ejaculation Treatment Major Product Offerings
7.8.4 Teva Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.8.5 Teva Key News
7.9 Sunrise Pharma
7.9.1 Sunrise Pharma Corporate Summary
7.9.2 Sunrise Pharma Business Overview
7.9.3 Sunrise Pharma Premature Ejaculation Treatment Major Product Offerings
7.9.4 Sunrise Pharma Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.9.5 Sunrise Pharma Key News
7.10 Regent Pacific
7.10.1 Regent Pacific Corporate Summary
7.10.2 Regent Pacific Business Overview
7.10.3 Regent Pacific Premature Ejaculation Treatment Major Product Offerings
7.10.4 Regent Pacific Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.10.5 Regent Pacific Key News
7.11 Torrent Pharma
7.11.1 Torrent Pharma Corporate Summary
7.11.2 Torrent Pharma Business Overview
7.11.3 Torrent Pharma Premature Ejaculation Treatment Major Product Offerings
7.11.4 Torrent Pharma Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.11.5 Torrent Pharma Key News
7.12 Vivus
7.12.1 Vivus Corporate Summary
7.12.2 Vivus Business Overview
7.12.3 Vivus Premature Ejaculation Treatment Major Product Offerings
7.12.4 Vivus Premature Ejaculation Treatment Revenue in Global (2016-2021)
7.12.5 Vivus Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Premature Ejaculation Treatment Market Opportunities & Trends in Global Market
Table 2. Premature Ejaculation Treatment Market Drivers in Global Market
Table 3. Premature Ejaculation Treatment Market Restraints in Global Market
Table 4. Key Players of Premature Ejaculation Treatment in Global Market
Table 5. Top Premature Ejaculation Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Premature Ejaculation Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Premature Ejaculation Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Premature Ejaculation Treatment Product Type
Table 9. List of Global Tier 1 Premature Ejaculation Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Premature Ejaculation Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Premature Ejaculation Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Premature Ejaculation Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Premature Ejaculation Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Premature Ejaculation Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Premature Ejaculation Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Premature Ejaculation Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Premature Ejaculation Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Premature Ejaculation Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Premature Ejaculation Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Premature Ejaculation Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Premature Ejaculation Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Premature Ejaculation Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Premature Ejaculation Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Premature Ejaculation Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Premature Ejaculation Treatment Product Offerings
Table 32. Pfizer Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Premature Ejaculation Treatment Product Offerings
Table 35. Novartis Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Premature Ejaculation Treatment Product Offerings
Table 38. Eli Lilly Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Premature Ejaculation Treatment Product Offerings
Table 41. Johnson & Johnson Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Premature Ejaculation Treatment Product Offerings
Table 44. GlaxoSmithKline Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Bayer Corporate Summary
Table 46. Bayer Premature Ejaculation Treatment Product Offerings
Table 47. Bayer Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Menarini Corporate Summary
Table 49. Menarini Premature Ejaculation Treatment Product Offerings
Table 50. Menarini Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Teva Corporate Summary
Table 52. Teva Premature Ejaculation Treatment Product Offerings
Table 53. Teva Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Sunrise Pharma Corporate Summary
Table 55. Sunrise Pharma Premature Ejaculation Treatment Product Offerings
Table 56. Sunrise Pharma Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Regent Pacific Corporate Summary
Table 58. Regent Pacific Premature Ejaculation Treatment Product Offerings
Table 59. Regent Pacific Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Torrent Pharma Corporate Summary
Table 61. Torrent Pharma Premature Ejaculation Treatment Product Offerings
Table 62. Torrent Pharma Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)
Table 63. Vivus Corporate Summary
Table 64. Vivus Premature Ejaculation Treatment Product Offerings
Table 65. Vivus Premature Ejaculation Treatment Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. Premature Ejaculation Treatment Segment by Type
Figure 2. Premature Ejaculation Treatment Segment by Application
Figure 3. Global Premature Ejaculation Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Premature Ejaculation Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Premature Ejaculation Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2020
Figure 8. By Type - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 12. US Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 24. China Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Premature Ejaculation Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Premature Ejaculation Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eli Lilly Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Johnson & Johnson Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. GlaxoSmithKline Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bayer Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Menarini Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Teva Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sunrise Pharma Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Regent Pacific Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Torrent Pharma Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Vivus Premature Ejaculation Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: Premature Ejaculation Treatment Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW